Your browser doesn't support javascript.
loading
Development of Quality of Life Questionnaire for Patients with Parkinson's Disease Undergoing STN-DBS.
Kawaguchi, Minako; Miyagi, Yasushi; Kishimoto, Junji; Samura, Kazuhiro; Tokunaga, Yutaka; Watari, Mari; Eguchi, Hiroko; Ueda, Shintaro; Iihara, Koji.
Afiliação
  • Kawaguchi M; Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University.
  • Miyagi Y; Department of Stereotactic and Functional Neurosurgery, Medical Co. LTA Fukuoka Mirai Hospital.
  • Kishimoto J; Center for Clinical and Translational Research, Kyushu University.
  • Samura K; Department of Neurosurgery, Saiseikai Karatsu Hospital.
  • Tokunaga Y; Department of Education and Clinical Psychology, Faculty of Humanities, Fukuoka University.
  • Watari M; Department of Neurology, Medical Co. LTA Fukuoka Mirai Hospital.
  • Eguchi H; Department of Nursing, Medical Co. LTA Fukuoka Mirai Hospital.
  • Ueda S; Telemedicine Development Center of Asia, International Medical Department, Kyushu University Hospital.
  • Iihara K; National Cerebral and Cardiovascular Center.
Neurol Med Chir (Tokyo) ; 61(8): 475-483, 2021 Aug 15.
Article em En | MEDLINE | ID: mdl-34148942
ABSTRACT
In device-aided therapy (DAT) for Parkinson's disease (PD), factors such as device-related adverse effects, psychological and lifestyle changes, and specific disease progression can affect the quality of life (QoL) of patients with advanced PD. However, there is no existing QoL scale that includes the effects of therapeutic devices. From a semi-structured interview with patients with PD undergoing deep brain stimulation (DBS), we extracted the content of utterances that were thought to affect the QoL and created a draft questionnaire consisting of 113 items. This questionnaire was administered to 54 other patients undergoing DBS, whose data were examined for reliability and validity by factor analysis, and finally, a 24-item PD QoL questionnaire for patients on DAT (PDQ-DAT) was developed. Presently, the PDQ-DAT is the only scale that can assess the QoL of patients on DAT, including the influence treatment devices have on them. In the future, it might be used to help in shared decision-making in medicine by incorporating the patient's sense of burden and values in the selection of treatment methods.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Parkinson / Núcleo Subtalâmico / Estimulação Encefálica Profunda Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Neurol Med Chir (Tokyo) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Parkinson / Núcleo Subtalâmico / Estimulação Encefálica Profunda Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Neurol Med Chir (Tokyo) Ano de publicação: 2021 Tipo de documento: Article